Skip to content

Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia Surgery

A Pilot Study of the Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05093049
Enrollment
10
Registered
2021-10-26
Start date
2021-10-22
Completion date
2022-08-17
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecomastia

Keywords

Renuvion, Helium Plasma

Brief summary

This is a prospective, multi-center, single-blinded, randomized study of up to 10 study subjects undergoing bilateral gynecomastia surgery with Renuvion APR System used as an adjunct procedure on one side. The study was conducted at a single investigational center in the United States.

Detailed description

This is a prospective, multi-center, single-blinded, randomized study of up to 10 study subjects undergoing bilateral gynecomastia surgery with Renuvion APR System used as an adjunct procedure on one side. The study was conducted at a single investigational center in the United States. At baseline, the grade of gynecomastia was recorded by side, male chest measurements will be taken, and pre-surgery photographs taken in the frontal, lateral, and oblique views. The gynecomastia surgery and Renuvion APR System use were as per investigator's standard clinical practice. During the procedure, fat transfer and treatment of the lateral chest and/or axilla was not allowed. The Renuvion APR System was used on one side only. The Renuvion treated side was randomized and the patient was blinded as to which side of the chest received Renuvion. Procedure data and adverse events were captured. Endermology was not allowed post-procedure. Post-procedure compression was used for 2-3 weeks with a standard compression vest for all subjects. Follow-up images, grade of gynecomastia, and male chest measurements were taken at D30/D90/D180. All images were assessed for correct identification of Renuvion-treated side by blinded Independent Photographic Reviewers (IPR) following the D180 visit. Following study participation, the subject was offered an optional balancing treatment to the side not previously treated with Renuvion.

Interventions

The Renuvion APR Handpiece (K191542) is a sterile, single use electrosurgical (monopolar) device intended to be used in conjunction with compatible generators for the percutaneous delivery of radiofrequency energy and/or helium plasma for cutting, coagulation and ablation of soft tissue. The Renuvion APR Handpiece is compatible with the Electrosurgical Generators BVX-200H/P (K170188), and APYX-JS3/RS3 (K192867) owned by Apyx Medical that are indicated for delivery of radiofrequency energy and/or helium gas plasma to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures.

PROCEDUREGynecomastia Correction Surgery

Gynecomastia correction surgery as per the investigators standard treatment of care utilizing liposuction.

Sponsors

Apyx Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male subjects, ages 18 - 75 years old. 2. ASA Physical Status Classification System Class I and Class II subjects. 3. Clinical diagnosis of primary or secondary Gynecomastia. 4. Gynecomastia Rohrich Grade IIA or higher. 5. Symmetrical gynecomastia Rohrich grades. 6. Symmetrical chest measurements (no more than 3% variance between sides). 7. Scheduled for Gynecomastia surgery. 8. Willing to have Renuvion APR System as an adjunct procedure on one side understanding that an optional balancing procedure may be provided post-study exit. 9. Understands and accepts the obligation not to undergo any other procedures or treatments in the areas to be treated during study participation. 10. Absence of physical conditions unacceptable to the investigator. 11. Willing and able to comply with protocol requirements, including study-required images/photos, assessments/measurements, and returning for follow-up visits. 12. Willing to release rights for the use of study photos, including in publication. 13. Able to read, understand, sign, and date the informed consent.

Exclusion criteria

1. Subjects without clinical diagnosis of primary Gynecomastia and/or a clinical diagnosis of gynecomastia with secondary causes such as medications, drugs, or testicular tumors. 2. Subjects presenting with ASA Physical Status Classification System Classes III or higher. 3. Gynecomastia Rohrich Grade I. 4. Non-symmetrical gynecomastia Rohrich grades. 5. Non-symmetrical chest measurements (more than 3% variance between sides). 6. Previous treatment or surgery in the breast area. 7. Active systemic or local skin disease that may alter wound healing. 8. Significant or uncontrolled medical condition that in the opinion of the investigator participation in the study may compromise the patient's health. 9. History of autoimmune disease (excluding Hashimoto's thyroiditis). 10. Known susceptibility to keloid formation or hypertrophic scarring. 11. Cancerous or pre-cancerous lesions in the area to be treated. 12. Possesses a surgically implanted electronic device (i.e. pacemaker). 13. Serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years. 14. Use of endermology post-procedure for the duration of the study. 15. Participation in any other investigational study within 30 days prior to consent and throughout study participation. 16. Subject who, in the opinion of the investigator, is not an appropriate candidate for the study.

Design outcomes

Primary

MeasureTime frameDescription
Analysis of Bilateral Occurrence of Adverse EventsThrough Day 180Analysis of bilateral occurrence of adverse events by study arm.

Secondary

MeasureTime frameDescription
Bilateral Analysis of Change to Soft-Tissue Pinch Thickness at the Inframammary FoldDay 30, 90, 180A measurement of soft-tissue pinch thickness at the inframammary fold by isolating skin and subcutaneous tissue at the inframammary fold, pinching firmly, and measuring the thickness with a caliper.
Bilateral Analysis of Male Chest MeasurementsDay 30, 90, 180Measurement of suprasternal notch to nipple, inter-nipple distance, suprasternal notch to nipple plane, midclavicular point to nipple, nipple plane to umbilicus, umbilicus to pubic symphysis, coracoid process to nipple plane, nipple plane to medial epicondyle, and coracoid process to medial epicondyle.
Bilateral Analysis of the Amount of Skin Excised During the Procedure by Gynecomastia Grade (Rohrich Classification)ProcedureBilateral measurement of the amount of skin excised during the procedure (if any) by Gynecomastia Grade (Rohrich Classification). Grade I (Minimal hypertrophy, \<250g of breast tissue, without ptosis) I A: Primarily glandular\* I B: Primarily fibrous\* Grade II (Moderate hypertrophy, 250-500g of breast tissue, without ptosis) I A: Primarily glandular\* I B: Primarily fibrous\* Grade III (Severe hypertrophy, \>500g of breast tissue, with grade I ptosis Glandular or fibrous\*) Grade IV (Severe hypertrophy with grade I or III ptosis) Glandular or fibrous\* \*Fatty and glandular tissue is determined by a pinch test medially, laterally, and beneath the nipple-areola complex
Gland Tissue Removal by Number of ParticipantsProcedureBilateral analysis of the number of subjects with gland tissue removed by the during the procedure. The technique utilized for subjects in this study was a mixed surgical technique. The Investigator removed progressive strips of gland in a radial fashion until optimal extraction by palpation was achieved.
Bilateral Analysis of Change to Soft-Tissue Pinch Thickness of the Upper PoleDay 30, 90, 180A measurement of the soft-tissue pinch thickness of the upper pole, by isolating skin and subcutaneous tissue superior to the breast parenchyma, pinching firmly, and measuring the thickness with a caliper.
Bilateral Subject Global Aesthetic Improvement ScaleDay 30, 90, 180The subject will complete a bilateral Subject Global Aesthetic Improvement Scale assessing overall aesthetic improvement in the treatment area. Rating scale: Very Much Improved, Much Improved, Improved, No Change, Worse, Much Worse, Very Much Worse
Bilateral Patient Satisfaction QuestionnaireDay 30, 90, 180The subject will complete a bilateral Patient Satisfaction Questionnaire for the evaluation of satisfaction for the right side and for the left side. Questions were Yes/No responses.
Correct Identification of Renuvion-treated Side by Blinded Independent Photographic ReviewersDay 180Three experienced, blinded photographic reviewers performed a qualitative analysis/review of pre-treatment and post-treatment sets of images for each subject. Images were provided in a blinded and randomized order. Each blinded reviewer choose which side of the chest was treated with gynecomastia correction surgery followed by Renuvion treatment. Success was the correct identification of treated side of the chest by at least 2 of the 3 reviewers.
Bilateral Physician Global Aesthetic Improvement ScaleDay 30, 90, 180The Principal Investigator, sub-investigator or qualified clinician delegated by the principal investigator, will complete a bilateral Physician Global Aesthetic Improvement Scale assessing overall aesthetic improvement in the treatment area. Rating scale: Very Much Improved, Much Improved, Improved, No Change, Worse, Much Worse, Very Much Worse

Countries

United States

Participant flow

Recruitment details

Patients were recruited from a single site in the United States.

Pre-assignment details

All ten subjects in need of gynecomastia correction surgery were treated in a bilateral randomized design. One side of the chest received gynecomastia surgery. The other side received gynecomastia surgery followed by treatment with Renuvion.

Participants by arm

ArmCount
All Subjects
Total of all reporting groups
10
Total10

Baseline characteristics

CharacteristicAll Subjects
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
Age, Continuous41 years
BMI26.5 kg/m^2
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
6 Participants
Region of Enrollment
United States
10 participants
Rohrich Classification of Gynecomastia
Grade IIA
8 Participants
Rohrich Classification of Gynecomastia
Grade IIB
2 Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
4 / 105 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Analysis of Bilateral Occurrence of Adverse Events

Analysis of bilateral occurrence of adverse events by study arm.

Time frame: Through Day 180

Population: Healthy, male adult subjects, ages 18 - 75 years old who meet the inclusion/exclusion criteria.

ArmMeasureGroupValue (NUMBER)
Gynecomastia Surgery Followed by RenuvionAnalysis of Bilateral Occurrence of Adverse EventsNumber of Expected Treatment Effects42 Number of Events
Gynecomastia Surgery Followed by RenuvionAnalysis of Bilateral Occurrence of Adverse EventsNumber of Adverse Events6 Number of Events
Gynecomastia Surgery OnlyAnalysis of Bilateral Occurrence of Adverse EventsNumber of Expected Treatment Effects38 Number of Events
Gynecomastia Surgery OnlyAnalysis of Bilateral Occurrence of Adverse EventsNumber of Adverse Events7 Number of Events
Secondary

Bilateral Analysis of Change to Soft-Tissue Pinch Thickness at the Inframammary Fold

A measurement of soft-tissue pinch thickness at the inframammary fold by isolating skin and subcutaneous tissue at the inframammary fold, pinching firmly, and measuring the thickness with a caliper.

Time frame: Day 30, 90, 180

ArmMeasureGroupValue (MEAN)Dispersion
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Change to Soft-Tissue Pinch Thickness at the Inframammary FoldChange from Baseline to D180-0.17 cmStandard Deviation 0.23
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Change to Soft-Tissue Pinch Thickness at the Inframammary FoldChange from Baseline to D30-0.11 cmStandard Deviation 0.022
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Change to Soft-Tissue Pinch Thickness at the Inframammary FoldChange from Baseline to D90-0.16 cmStandard Deviation 0.27
Gynecomastia Surgery OnlyBilateral Analysis of Change to Soft-Tissue Pinch Thickness at the Inframammary FoldChange from Baseline to D30-0.24 cmStandard Deviation 0.29
Gynecomastia Surgery OnlyBilateral Analysis of Change to Soft-Tissue Pinch Thickness at the Inframammary FoldChange from Baseline to D90-0.28 cmStandard Deviation 0.22
Gynecomastia Surgery OnlyBilateral Analysis of Change to Soft-Tissue Pinch Thickness at the Inframammary FoldChange from Baseline to D180-0.29 cmStandard Deviation 0.26
Secondary

Bilateral Analysis of Change to Soft-Tissue Pinch Thickness of the Upper Pole

A measurement of the soft-tissue pinch thickness of the upper pole, by isolating skin and subcutaneous tissue superior to the breast parenchyma, pinching firmly, and measuring the thickness with a caliper.

Time frame: Day 30, 90, 180

ArmMeasureGroupValue (MEAN)Dispersion
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Change to Soft-Tissue Pinch Thickness of the Upper PoleChange from Baseline to D30-0.29 cmStandard Deviation 0.37
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Change to Soft-Tissue Pinch Thickness of the Upper PoleChange from Baseline to D90-0.49 cmStandard Deviation 0.51
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Change to Soft-Tissue Pinch Thickness of the Upper PoleChange from Baseline to D180-0.59 cmStandard Deviation 0.53
Gynecomastia Surgery OnlyBilateral Analysis of Change to Soft-Tissue Pinch Thickness of the Upper PoleChange from Baseline to D30-0.31 cmStandard Deviation 0.52
Gynecomastia Surgery OnlyBilateral Analysis of Change to Soft-Tissue Pinch Thickness of the Upper PoleChange from Baseline to D90-0.59 cmStandard Deviation 0.51
Gynecomastia Surgery OnlyBilateral Analysis of Change to Soft-Tissue Pinch Thickness of the Upper PoleChange from Baseline to D180-0.72 cmStandard Deviation 0.5
Secondary

Bilateral Analysis of Male Chest Measurements

Measurement of suprasternal notch to nipple, inter-nipple distance, suprasternal notch to nipple plane, midclavicular point to nipple, nipple plane to umbilicus, umbilicus to pubic symphysis, coracoid process to nipple plane, nipple plane to medial epicondyle, and coracoid process to medial epicondyle.

Time frame: Day 30, 90, 180

ArmMeasureGroupValue (MEAN)
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Umbilicus from Baseline to D90-0.4 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Internipple Distance from Baseline to D30-0.4 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Umbilicus from Baseline to D180-0.3 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple Plane from Baseline to D90-3.5 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Umbilicus to Pubic Symphysis from Baseline to D300 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple from Baseline to D30-0.1 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Umbilicus to Pubic Symphysis from Baseline to D900 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple Plane from Baseline to D180-3.4 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Umbilicus to Pubic Symphysis from Baseline to D1800 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Internipple Distance from Baseline to D90-0.7 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Nipple Plane from Baseline to D300.1 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Midclavicular Point to Nipple from Baseline to D300.1 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Nipple Plane from Baseline to D900.2 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple from Baseline to D180-0.3 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Nipple Plane from Baseline to D1800.1 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Midclavicular Point to Nipple from Baseline to D900.2 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Medial Epicondyle from Baseline to D30-0.1 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Internipple Distance from Baseline to D180-0.8 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Medial Epicondyle from Baseline to D90-0.2 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Medial Epicondyle from Baseline to D180-0.2 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Midclavicular Point to Nipple from Baseline to D1800.1 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Medial Epicondyle from Baseline to D300 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple from Baseline to D90-0.1 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Medial Epicondyle from Baseline to D900 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Umbilicus from Baseline to D30-0.4 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Medial Epicondyle from Baseline to D1800 cm
Gynecomastia Surgery Followed by RenuvionBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple Plane from Baseline to D30-1.8 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Medial Epicondyle from Baseline to D1800 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple from Baseline to D300 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple from Baseline to D900 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple from Baseline to D180-0.1 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Internipple Distance from Baseline to D30-0.4 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Internipple Distance from Baseline to D90-0.7 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Internipple Distance from Baseline to D180-0.8 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple Plane from Baseline to D30-2.0 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple Plane from Baseline to D90-3.5 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Suprasternal Notch to Nipple Plane from Baseline to D180-3.5 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Midclavicular Point to Nipple from Baseline to D300 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Midclavicular Point to Nipple from Baseline to D900.3 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Midclavicular Point to Nipple from Baseline to D1800.3 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Umbilicus from Baseline to D30-0.4 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Umbilicus from Baseline to D90-0.4 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Umbilicus from Baseline to D180-0.3 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Umbilicus to Pubic Symphysis from Baseline to D300 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Umbilicus to Pubic Symphysis from Baseline to D900 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Umbilicus to Pubic Symphysis from Baseline to D1800 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Nipple Plane from Baseline to D30-0.1 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Nipple Plane from Baseline to D900.1 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Nipple Plane from Baseline to D1800.2 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Medial Epicondyle from Baseline to D30-0.1 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Medial Epicondyle from Baseline to D180-0.4 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Medial Epicondyle from Baseline to D300 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Coracoid Process to Medial Epicondyle from Baseline to D900 cm
Gynecomastia Surgery OnlyBilateral Analysis of Male Chest MeasurementsChange in Nipple Plane to Medial Epicondyle from Baseline to D90-0.3 cm
Secondary

Bilateral Analysis of the Amount of Skin Excised During the Procedure by Gynecomastia Grade (Rohrich Classification)

Bilateral measurement of the amount of skin excised during the procedure (if any) by Gynecomastia Grade (Rohrich Classification). Grade I (Minimal hypertrophy, \<250g of breast tissue, without ptosis) I A: Primarily glandular\* I B: Primarily fibrous\* Grade II (Moderate hypertrophy, 250-500g of breast tissue, without ptosis) I A: Primarily glandular\* I B: Primarily fibrous\* Grade III (Severe hypertrophy, \>500g of breast tissue, with grade I ptosis Glandular or fibrous\*) Grade IV (Severe hypertrophy with grade I or III ptosis) Glandular or fibrous\* \*Fatty and glandular tissue is determined by a pinch test medially, laterally, and beneath the nipple-areola complex

Time frame: Procedure

Population: None of the patients in this study had skin excised during treatment, thus none were analyzed for this endpoint which was looking at how much skin was excised by their Gynecomastia Grade. In the case of this study, it was none.

ArmMeasureGroupValue
UnknownBilateral Analysis of the Amount of Skin Excised During the Procedure by Gynecomastia Grade (Rohrich Classification)Grade 1
UnknownBilateral Analysis of the Amount of Skin Excised During the Procedure by Gynecomastia Grade (Rohrich Classification)Grade II
UnknownBilateral Analysis of the Amount of Skin Excised During the Procedure by Gynecomastia Grade (Rohrich Classification)Grade III
UnknownBilateral Analysis of the Amount of Skin Excised During the Procedure by Gynecomastia Grade (Rohrich Classification)Grade IV
Secondary

Bilateral Patient Satisfaction Questionnaire

The subject will complete a bilateral Patient Satisfaction Questionnaire for the evaluation of satisfaction for the right side and for the left side. Questions were Yes/No responses.

Time frame: Day 30, 90, 180

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Gynecomastia Surgery Followed by RenuvionBilateral Patient Satisfaction QuestionnaireNoted improvement in skin texture in the treatment area6 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Patient Satisfaction QuestionnaireBelieved this side side looked better3 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Patient Satisfaction QuestionnaireNoted more chest definition8 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Patient Satisfaction QuestionnaireRequested a balancing procedure7 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Patient Satisfaction QuestionnaireNoticed a difference in the sides of the chest9 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Patient Satisfaction QuestionnaireWould recommend the procedure to a friend9 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Patient Satisfaction QuestionnaireHappy with the results9 Participants
Gynecomastia Surgery OnlyBilateral Patient Satisfaction QuestionnaireWould recommend the procedure to a friend10 Participants
Gynecomastia Surgery OnlyBilateral Patient Satisfaction QuestionnaireHappy with the results10 Participants
Gynecomastia Surgery OnlyBilateral Patient Satisfaction QuestionnaireNoted more chest definition8 Participants
Gynecomastia Surgery OnlyBilateral Patient Satisfaction QuestionnaireNoted improvement in skin texture in the treatment area5 Participants
Gynecomastia Surgery OnlyBilateral Patient Satisfaction QuestionnaireNoticed a difference in the sides of the chest9 Participants
Gynecomastia Surgery OnlyBilateral Patient Satisfaction QuestionnaireBelieved this side side looked better6 Participants
Gynecomastia Surgery OnlyBilateral Patient Satisfaction QuestionnaireRequested a balancing procedure7 Participants
Secondary

Bilateral Physician Global Aesthetic Improvement Scale

The Principal Investigator, sub-investigator or qualified clinician delegated by the principal investigator, will complete a bilateral Physician Global Aesthetic Improvement Scale assessing overall aesthetic improvement in the treatment area. Rating scale: Very Much Improved, Much Improved, Improved, No Change, Worse, Much Worse, Very Much Worse

Time frame: Day 30, 90, 180

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD30Very Much Improved2 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD30Much Improved5 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD30Improved2 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD30No Change1 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD30Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD30Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD30Very Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD90Very Much Improved6 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD90Much Improved2 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD90Improved2 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD90No Change0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD90Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD90Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD90Very Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD180Very Much Improved6 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD180Much Improved4 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD180Improved0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD180No Change0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD180Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD180Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Physician Global Aesthetic Improvement ScaleD180Very Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD90No Change0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD30Very Much Improved2 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD180Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD30Much Improved4 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD90Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD30Improved4 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD180Improved1 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD30No Change0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD90Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD30Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD180Very Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD30Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD90Very Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD30Very Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD180No Change0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD90Very Much Improved2 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD180Very Much Improved6 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD90Much Improved7 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD180Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD90Improved1 Participants
Gynecomastia Surgery OnlyBilateral Physician Global Aesthetic Improvement ScaleD180Much Improved3 Participants
Secondary

Bilateral Subject Global Aesthetic Improvement Scale

The subject will complete a bilateral Subject Global Aesthetic Improvement Scale assessing overall aesthetic improvement in the treatment area. Rating scale: Very Much Improved, Much Improved, Improved, No Change, Worse, Much Worse, Very Much Worse

Time frame: Day 30, 90, 180

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD30Very Much Improved4 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD30Much Improved4 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD30Improved2 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD30No Change0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD30Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD30Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD30Very Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD90Very Much Improved4 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD90Much Improved5 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD90Improved1 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD90No Change0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD90Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD90Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD90Very Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD180Very Much Improved5 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD180Much Improved3 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD180Improved2 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD180No Change0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD180Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD180Much Worse0 Participants
Gynecomastia Surgery Followed by RenuvionBilateral Subject Global Aesthetic Improvement ScaleD180Very Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD90No Change0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD30Very Much Improved3 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD180Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD30Much Improved4 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD90Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD30Improved3 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD180Improved1 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD30No Change0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD90Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD30Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD180Very Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD30Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD90Very Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD30Very Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD180No Change0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD90Very Much Improved5 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD180Very Much Improved5 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD90Much Improved5 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD180Much Worse0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD90Improved0 Participants
Gynecomastia Surgery OnlyBilateral Subject Global Aesthetic Improvement ScaleD180Much Improved4 Participants
Secondary

Correct Identification of Renuvion-treated Side by Blinded Independent Photographic Reviewers

Three experienced, blinded photographic reviewers performed a qualitative analysis/review of pre-treatment and post-treatment sets of images for each subject. Images were provided in a blinded and randomized order. Each blinded reviewer choose which side of the chest was treated with gynecomastia correction surgery followed by Renuvion treatment. Success was the correct identification of treated side of the chest by at least 2 of the 3 reviewers.

Time frame: Day 180

ArmMeasureValue (NUMBER)
Gynecomastia Surgery Followed by RenuvionCorrect Identification of Renuvion-treated Side by Blinded Independent Photographic Reviewers5 Correctly identified side.
Secondary

Gland Tissue Removal by Number of Participants

Bilateral analysis of the number of subjects with gland tissue removed by the during the procedure. The technique utilized for subjects in this study was a mixed surgical technique. The Investigator removed progressive strips of gland in a radial fashion until optimal extraction by palpation was achieved.

Time frame: Procedure

ArmMeasureGroupValue (NUMBER)
Gynecomastia Surgery Followed by RenuvionGland Tissue Removal by Number of ParticipantsNo Excision8 participants
Gynecomastia Surgery Followed by RenuvionGland Tissue Removal by Number of ParticipantsExcision2 participants
Gynecomastia Surgery OnlyGland Tissue Removal by Number of ParticipantsNo Excision8 participants
Gynecomastia Surgery OnlyGland Tissue Removal by Number of ParticipantsExcision2 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026